Sale!

IHC ER, PR, HER2NEU, and KI67 Test Cost

Original price was: 2,400 د.إ.Current price is: 1,800 د.إ.

-25%

The IHC ER, PR, HER2NEU, and Ki67 test is a comprehensive panel performed at DNA Labs UAE, designed to evaluate the presence and extent of specific biomarkers in breast cancer tumors. This test plays a crucial role in the diagnosis, treatment planning, and prognosis of breast cancer. Here’s a brief overview of each component:

– **ER (Estrogen Receptor):** Tests for the presence of estrogen receptors in the cancer cells. Positive results indicate that the cancer may respond to hormonal therapies.

– **PR (Progesterone Receptor):** Similar to ER, this tests for the presence of progesterone receptors. ER and PR statuses together help in determining the hormone responsiveness of the tumor.

– **HER2NEU (Human Epidermal Growth Factor Receptor 2):** Assesses the overexpression of the HER2 protein on the surface of cancer cells, which is associated with more aggressive growth. HER2-positive cancers may be treated with targeted therapies.

– **Ki67:** This marker is used to determine the proliferation rate of cancer cells, indicating how quickly the cancer is likely to grow and spread.

At DNA Labs UAE, this panel is offered at a cost of 1800 AED. The results from this test are pivotal for clinicians in making informed decisions regarding the most effective treatment strategies for breast cancer patients, tailored to the molecular profile of their tumors.

Description

IHC ER+PR+HER2NEU+KI67 Test Cost AED:1800.0

Symptoms, Diagnosis, and Test Details:

The IHC ER+PR+HER2NEU+KI67 test refers to the results of immunohistochemistry (IHC) testing on a tumor sample. This test is used to determine the hormone receptor status, HER2 status, and proliferation rate of the tumor, which can help guide treatment decisions.

The components required for this test include tissue in 10% Neutral Buffered Formalin. The test is performed using the method of histopathology and falls under the genetics test type. The test is conducted by a general surgeon in the test department.

Test Cost: AED 1800.0

Sample Condition: Tissue

Report Delivery: 6 days

Pre Test Information: The IHC ER+PR+HER2NEU+KI67 test can only be done with a doctor’s prescription. However, prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Components:

ER: Estrogen receptor
PR: Progesterone receptor
HER2NEU: Human epidermal growth factor receptor 2
KI67: A marker for cell proliferation

The ER and PR status indicate whether the tumor cells have receptors for estrogen and progesterone, respectively. ER+ and PR+ means the tumor cells have these receptors, indicating that hormonal therapies targeting these receptors may be effective.

HER2NEU refers to the HER2 protein, which is involved in cell growth and division. HER2NEU+ means that the tumor cells overexpress the HER2 protein. This can be important for treatment decisions, as HER2-targeted therapies may be effective in these cases.

KI67 is a marker for cell proliferation, indicating how rapidly the tumor cells are dividing. High KI67 levels suggest a more aggressive tumor with a higher growth rate.

Overall, the IHC ER+PR+HER2NEU+KI67 result provides important information about the tumor’s hormone receptor status, HER2 status, and proliferation rate, which can help guide treatment decisions.

Test Name	IHC ERandPRandHER2NEUandKI67 Test
Components	Tissue in 10% Neutral Buffered Formalin
Price	1800.0 AED
Sample Condition	Tissue
Report Delivery	6 days
Method	Histopathology
Test type	Genetics
Doctor	General Surgeon
Test Department:
Pre Test Information	IHC ER+PR+HER2NEU+KI67 can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details	IHC ER+PR+HER2NEU+KI67 refers to the results of immunohistochemistry (IHC) testing on a tumor sample. The abbreviations stand for: – ER: Estrogen receptor – PR: Progesterone receptor – HER2NEU: Human epidermal growth factor receptor 2 – KI67: A marker for cell proliferation The ER and PR status indicate whether the tumor cells have receptors for estrogen and progesterone, respectively. ER+ and PR+ means the tumor cells have these receptors, indicating that hormonal therapies targeting these receptors may be effective. HER2NEU refers to the HER2 protein, which is involved in cell growth and division. HER2NEU+ means that the tumor cells overexpress the HER2 protein. This can be important for treatment decisions, as HER2-targeted therapies may be effective in these cases. KI67 is a marker for cell proliferation, indicating how rapidly the tumor cells are dividing. High KI67 levels suggest a more aggressive tumor with a higher growth rate. Overall, the IHC ER+PR+HER2NEU+KI67 result provides important information about the tumor’s hormone receptor status, HER2 status, and proliferation rate, which can help guide treatment decisions.